- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 152.55M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $644.52M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $646.57M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $34.47M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $30.71M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $348.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $362.99M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $408.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $437.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.1B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.14B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $976.29M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $998.72M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.43B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.43B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 151.35M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $47.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $231.22M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $259.25M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $37.78M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.9M |
| Net Income | Q1 2025 · Mar 31, 2024 | $2.17M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $8.41M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $55.09M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $98.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $153.4M |